PubRank

Kari Otterdal

Author PubWeight™ 23.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 2009 1.25
2 Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008 1.22
3 Atherosclerotic plaque stability--what determines the fate of a plaque? Prog Cardiovasc Dis 2008 1.18
4 Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol 2006 1.14
5 A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol 2008 1.06
6 Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen 2011 0.99
7 Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 2004 0.97
8 Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation 2003 0.97
9 Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 2004 0.88
10 Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. J Infect 2008 0.88
11 Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation. Diabetes 2011 0.86
12 Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux. J Nutr 2006 0.85
13 Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. Circ Res 2008 0.83
14 Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J 2005 0.83
15 Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome. Eur J Endocrinol 2009 0.83
16 Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Fail 2008 0.82
17 Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol 2006 0.82
18 High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovasc Res 2008 0.82
19 Activated platelets and atherosclerosis. Expert Rev Cardiovasc Ther 2010 0.81
20 The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects. J Nutr 2008 0.81
21 Tumor necrosis factor superfamily molecules in acute coronary syndromes. Ann Med 2010 0.79
22 Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies. PLoS One 2012 0.79
23 The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis. Thromb Haemost 2009 0.78
24 The complex role of T-cell-based immunity in atherosclerosis. Curr Atheroscler Rep 2008 0.76
25 Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection. BMC Infect Dis 2014 0.75
26 A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells. PLoS One 2012 0.75
27 Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment. Eur J Endocrinol 2011 0.75
28 Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment. J Clin Endocrinol Metab 2014 0.75